Intelligent Multi-Signal Fluorescent Probe System for Enhanced Tumor Diagnosis and Treatment

A novel system integrating a multi-signal fluorescent probe with AI, IoT, blockchain, and nanomaterial technologies for early tumor diagnosis, personalized treatment, and optimized patient data management.

The original patent disclosed a multi-signal fluorescent probe for early tumor diagnosis, but its limitations included manual data analysis, lack of integration with advanced technologies, and limited scalability. The new inventive concept addresses these limitations by incorporating AI, IoT, blockchain, and nanomaterial technologies to create a more powerful, efficient, and personalized system.

The system consists of a multi-signal fluorescent probe, an AI module for data analysis and diagnosis, an IoT-enabled biosensor for real-time biomarker detection, a blockchain-based patient data management system for secure and transparent data storage, and a nanomaterial-based delivery system for targeted probe delivery. The AI module analyzes biomarker data and provides a diagnosis report, while the blockchain system ensures secure and transparent patient data management. The IoT-enabled biosensor enables real-time biomarker detection, and the nanomaterial-based delivery system enhances probe delivery efficiency.

The new claims introduce a synergistic combination of distinct technologies, including AI, IoT, blockchain, and nanomaterials, which enables a more powerful, efficient, and personalized system for tumor diagnosis and treatment. The integration of these technologies with the original multi-signal fluorescent probe constitutes a non-obvious improvement over the prior art.

Alternative embodiments may include using different AI algorithms, varying the type of nanomaterial used, or integrating additional technologies such as robotics or 3D printing. Variations may include adapting the system for different types of cancer or using the system for other medical applications.

The intelligent multi-signal fluorescent probe system has significant commercial potential in the medical diagnostics and treatment industries, particularly in the areas of cancer diagnosis and personalized medicine. The system's ability to provide early diagnosis, personalized treatment, and optimized patient data management makes it an attractive solution for hospitals, research institutions, and pharmaceutical companies.